Abstract: The present invention relates to a method of preparing a symmetrical phosphate-based compound. According to the method of the present invention, since a dinucleating agent is used in a hydrophobic solvent under a base-free condition, the yield of a desired compound may be increased due to excellent reaction stability and reduced side reactions.

Abstract: The present invention relates to a method of preparing an organosulfur compound, and more particularly, to a method of preparing an organosulfur compound including a step of synthesizing an organosulfur compound by reacting specific compounds with a metal hypohalite under a ruthenium catalyst in a mixed solvent containing water and an organic solvent, wherein reaction temperature during the synthesis is 0 to 25° C. According to the present invention, the present invention has an effect of providing an organosulfur compound preparation method capable of preparing an organosulfur compound in high yield due to excellent reaction stability, short reaction time, and reduced side reactions.

Abstract: The present invention relates to a method of preparing an organosulfur compound, and more particularly, to a method of preparing an organosulfur compound including a step of synthesizing an organosulfur compound by reacting specific compounds with a metal hypohalite under a ruthenium catalyst in a mixed solvent containing water and an organic solvent, wherein the metal hypohalite is introduced in a solid state and a portion thereof reacts in an undissolved state. According to the present invention, the present invention has an effect of providing an organosulfur compound preparation method capable of preparing an organosulfur compound in high yield due to excellent reaction stability, short reaction time, and reduced side reactions.

Abstract: The present invention relates to an organic compound, an organic light-emitting diode including the organic compound, and a display device including the organic light-emitting diode. More particularly, the present invention relates to an organic compound including a compound presented by Chemical Formula 1 and being capable of improving luminous efficacy, thermal stability, and lifespan properties, an organic light-emitting diode including the organic compound, and a display device including the organic light-emitting diode.

Abstract: The present invention relates to an organic compound, an organic light-emitting diode including the organic compound, and a display device including the organic light-emitting diode. More particularly, the present invention relates to an organic compound including a compound represented by Chemical Formula 1 and being capable of improving luminous efficacy, thermal stability, and lifespan properties; an organic light-emitting diode including the organic compound; and a display device including the organic light-emitting diode.

Abstract: Provided are a compound represented by the following Chemical Formulas and an organic light emitting device comprising the same.

Abstract: Provided are a compound represented by the following Chemical Formulas and an organic light emitting device comprising the same.

Abstract: The present invention provides a compound represented by Chemical Formula 1, and a light emitting device comprising the same.

Abstract: The present invention provides a double-stranded RNA structure, which comprises a polymer compound covalently bonded to a double-helix oligo RNA useful for the treatment of diseases, particularly cancer, in order to enhance the delivery of the double-helix oligo RNA, and further comprises a target-specific ligand bonded thereto, a preparation method thereof, and a technique of delivering the double-helix oligo RNA in a target-specific manner using the RNA structure. A nanoparticle composed of the ligand-bonded double-helix oligo RNA structures can efficiently deliver the double-helix oligo RNA to a target, and thus can exhibit the activity of the double-helix oligo RNA even when the double-helix oligo RNA is administered at a relatively low concentration. Also, it can prevent the non-specific delivery of the double-helix oligo RNA into other organs and cells.